Lesaffre International   Report issue

For profit Phase 4
Founded: Marcq-en-Baroeul France (1853)
Status: No NME R&D (1853)

Organization Overview

First Clinical Trial
2011
NCT00977587
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Lesaffre International

Active Ingredients

Drugs in Phase 4 Trials (1)

Key: Lesaffre International (0) Acquired (1)

chondroitin (1 trial)

Drugs in Other Trials (3)

saccharomyces cerevisiae (7 trials)

yeast cell walls (1 trial)

zinc dichloride (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 8
  • # of Trial APIs: 4